GBM and Lomustine
Apr 14, 2022•2 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. Howard Colman discusses the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage.
Show references: https://journals.lww.com/neurotodayonline/Fulltext/2021/09160/A_Glioblastoma_Drug_Is_Abruptly_Withdrawn_from.6.aspx
For the best experience, listen in Metacast app for iOS or Android